Purchase Order 75N90020P00544

The NIH Clinical Center issued a purchase order to EMD Millipore Corp for Milliplex Mouse/Chemokine Magnetic Beads valued at $12,408.00 on August 13, 2020. Performance will be completed in Chicago, Illinois. This firm fixed price order addresses the administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability. The ultimate completion date is August 31,...

<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp on June 26, 2019, with a ceiling value of $19,471.10 for laboratory products and services. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms and has an ultimate completion date of July 5, 2019.</p>

<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp for $24,931.52 on June 28, 2018, with ultimate completion on July 16, 2018. The order covers deob of expiring lines at firm fixed price. Place of performance is Bethesda, Maryland.</p>

<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp valued at $14,943.98 on August 1, 2018, with final completion set for August 7, 2018. The order, issued under firm fixed price terms with no set-aside, covers deobstruction of expiring product lines. Performance occurs in Bethesda, Maryland.</p>

EMD Millipore Corporation has been awarded a $24,850 firm fixed price purchase order by the National Institutes of Health Clinical Center to provide products or services from June 26, 2023 through July 31, 2023. The award was issued using the NIH's Clinical Center blanket purchase agreement vehicle to procure unspecified items or services in support of the agency's biomedical research programs. EMD Millipore Corporation will perform as the prime contractor, with all work taking place in...

<p>The NIH Clinical Center issued a purchase order to EMD Millipore Corp on February 28, 2019, for $10,687.50 at firm fixed price. Place of performance is Bethesda, Maryland. The order ultimate completion date is March 6, 2019. No set-aside was used. The source does not specify the products or services procured under this order.</p>

<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp valued at $14,937.60 on May 2, 2019, with completion by May 13, 2019. No set-aside applied. Performance occurs in Bethesda, Maryland. The order procures laboratory products and supplies, consistent with EMD Millipore's portfolio of filtration systems, consumables, and scientific equipment for federal research facilities. The contract carries firm fixed price terms.</p>

<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp valued at $24,931.52 on February 14, 2019, with completion scheduled for February 20, 2019. No small business set-aside applies. Work is performed at Bethesda, Maryland. The order covers laboratory products and supplies on a firm fixed price basis. The source does not disclose the specific product categories or originating solicitation reference.</p>

EMD Millipore Corporation has been awarded a firm fixed-price purchase order valued at approximately $13,000 by the National Institutes of Health Clinical Center of the Department of Health and Human Services. Under this contract, EMD Millipore will provide unspecified products or services to the NIH Clinical Center in Burlington, Massachusetts over a one-year period of performance beginning in October 2023. As the prime contractor, EMD Millipore will be responsible for fulfilling the contract...

This is a firm-fixed price purchase order award to EMD Millipore Corporation by the Department of Health and Human Services National Institutes of Health Clinical Center for a product called INTELLIFLEX. The total potential value of the award is $136,220.50 and the completion date is September 30, 2023. The award is not set aside for any socioeconomic category. EMD Millipore Corporation, as the prime contractor, will provide laboratory products and services to support biomedical research, drug...